Mechanisms of thrombosis in cancer

被引：91

作者：

Falanga, Anna ^{[1
]}

Russo, Laura ^{[1
]}

Verzeroli, Cristina ^{[1
]}

机构：

[1] Osped Riuniti Bergamo, Div Immunohematol & Transfus Med, I-24128 Bergamo, Italy

来源：

THROMBOSIS RESEARCH | 2013年 / 131卷

关键词：

Tumor; Venous thromboembolism; Microparticles; Tissue factor; Hypercoagulability; VENOUS THROMBOEMBOLISM; TISSUE FACTOR; RISK-FACTORS; TUMOR-CELLS; VIENNA CANCER; PROCOAGULANT; MICROPARTICLES; CHEMOTHERAPY; ANGIOGENESIS; CARCINOMA;

D O I：

10.1016/S0049-3848(13)70024-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with cancer are at high risk of developing thrombosis. The pathogenesis of blood coagulation activation in cancer patients is complex involves both clinical and biological factors. The thrombotic risk varies according to the type of malignancy and its disease stage, and is increased by concomitant patient-related thrombotic risk factors (i.e. advanced age, infection, heart disease). In addition, the tumor cell-specific prothrombotic properties and the host cell inflammatory response dramatically contribute to the risk of thrombosis in these patients. The current development of risk assessment models to predict thrombosis in cancer is important for identifying high-risk patients and predispose the adequate preventive measures. In this review we provide an overview of the principal mechanisms of thrombosis in cancer, including clinical and biological risk factors, and a summary of risk assessment tools to predict thrombosis in the single patient. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：S59 / S62

页数：4

共 34 条

[1] A clinical outcome-based prospective study on venous thromboembolism after cancer surgery -: The @RISTOS project [J].

Agnelli, G ;

Bolis, G ;

Capussotti, L ;

Scarpa, RM ;

Tonelli, F ;

Bonizzoni, E ;

Moia, M ;

Parazzini, F ;

Rossi, R ;

Sonaglia, F ;

Valarani, B ;

Bianchini, C ;

Gussoni, G ;

Andreoni, B ;

Biffi, R ;

Cenciarelli, S ;

Capussotti, L ;

Calgaro, M ;

Polastri, R ;

Zorzi, D ;

Mazzini, G ;

Tubaro, A ;

Perna, R ;

Vicentini, C ;

Montemurro, S ;

Caliandro, C ;

Ruggeri, E ;

Gennari, L ;

Brocchi, A ;

Quagliuolo, V ;

Scarpa, RM ;

Ragni, F ;

Conti, G ;

Cretarola, E ;

Pagliarulo, A ;

D'Achille, G ;

Bartoli, A ;

Bussotti, C ;

Ricci, E ;

Servoli, A ;

Carrieri, G ;

Corvasce, T ;

Disabato, G ;

Moretti, R ;

Bencini, L ;

Cantafio, S ;

Scatizzi, M ;

Scambia, G ;

Foti, E ;

Frigerio, L .

ANNALS OF SURGERY, 2006, 243 (01) :89-95

[2] High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) [J].

Ay, Cihan ;

Simanek, Ralph ;

Vormittag, Rainer ;

Dunkler, Daniela ;

Alguel, Guelay ;

Koder, Silvia ;

Kornek, Gabriela ;

Marosi, Christine ;

Wagner, Oswald ;

Zielinski, Christoph ;

Pabinger, Ingrid .

BLOOD, 2008, 112 (07) :2703-2708

[3] Prediction of venous thromboembolism in cancer patients [J].

Ay, Cihan ;

Dunkler, Daniela ;

Marosi, Christine ;

Chiriac, Alexandru-Laurentiu ;

Vormittag, Rainer ;

Simanek, Ralph ;

Quehenberger, Peter ;

Zielinski, Christoph ;

Pabinger, Ingrid .

BLOOD, 2010, 116 (24) :5377-5382

[4] D-Dimer and Prothrombin Fragment 1+2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study [J].

Ay, Cihan ;

Vormittag, Rainer ;

Dunkler, Daniela ;

Simanek, Ralph ;

Chiriac, Alexandru-Laurentiu ;

Drach, Johannes ;

Quehenberger, Peter ;

Wagner, Oswald ;

Zielinski, Christoph ;

Pabinger, Ingrid .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) :4124-4129

[5]

Baum M, 2002, LANCET, V359, P2131

[6] Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia [J].

Bennett, Charles L. ;

Silver, Samuel M. ;

Djulbegovic, Benjamin ;

Samaras, Athena T. ;

Blau, C. Anthony ;

Gleason, Kara J. ;

Barnato, Sara E. ;

Elverman, Kathleen M. ;

Courtney, D. Mark ;

McKoy, June M. ;

Edwards, Beatrice J. ;

Tigue, Cara C. ;

Raisch, Dennis W. ;

Yarnold, Paul R. ;

Dorr, David A. ;

Kuzel, Timothy M. ;

Tallman, Martin S. ;

Trifilio, Steven M. ;

West, Dennis P. ;

Lai, Stephen Y. ;

Henke, Michael .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (08) :914-924

[7] Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer [J].

Bennett, Charles L. ;

Angelotta, Cara ;

Yarnold, Paul R. ;

Evens, Andrew M. ;

Zonder, Jeffrey A. ;

Raisch, Dennis W. ;

Richardson, Paul .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (21) :2558-2560

[8] Selectins facilitate carcinoma metastasis and heparin can prevent them [J].

Borsig, L .

NEWS IN PHYSIOLOGICAL SCIENCES, 2004, 19 :16-21

[9] The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma - A systematic review [J].

Deitcher, SR ;

Gomes, MPV .

CANCER, 2004, 101 (03) :439-449

[10] Microvesicle-associated tissue factor and Trousseau's syndrome [J].

Del Conde, I. ;

Bharwani, L. D. ;

Dietzen, D. J. ;

Pendurthi, U. ;

Thiagarajan, P. ;

Lopez, J. A. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (01) :70-74

← 1 2 3 4 →